The proposed study will test the hypothesis that Propranolol, fenofibrate and fenofibrate
plus propranolol have therapeutic, physiological, and metabolic effects that will improve
clinical outcomes, and the long-term recovery, rehabilitation, and QOL in burned patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Collaborators:
National Institute of General Medical Sciences (NIGMS) Shriners Hospitals for Children